Outcomes of congenital heart disease in late preterm infants: double jeopardy?

Girija Natarajan1, Sreedhar R Anne, Sanjeev Aggarwal

  • 1Department of Pediatrics, Wayne State University, Children's Hospital of Michigan, Detroit, MI 48201, USA.

Insights

Late preterm infants with congenital heart defects face higher risks for complications and death compared to term infants. These findings emphasize the vulnerability of premature infants with heart conditions requiring surgery.

Area of Science:

  • Neonatal surgery
  • Pediatric cardiology
  • Perinatology

Background:

  • Congenital heart defects (CHDs) are a significant concern in neonates.
  • Late preterm infants (34-36 6/7 weeks gestation) may have different outcomes compared to term infants when CHDs require surgical intervention.

Purpose of the Study:

  • To compare surgical outcomes in late preterm infants with CHDs versus term infants with CHDs.
  • To identify specific vulnerabilities and complications in late preterm infants undergoing cardiac surgery.

Main Methods:

  • Retrospective chart review of consecutive late preterm and term infants with CHDs.
  • Infants included required surgical intervention during their initial hospital admission.
  • Comparison of outcomes between late preterm (n=26) and term (n=62) infant groups.

Main Results:

  • Late preterm infants had significantly earlier gestation, lower birth weight, and were older at the time of surgery.
  • Higher rates of prostaglandin E1 (PGE1) infusion, preoperative pressor use, and mortality were observed in the late preterm group.
  • Late preterm infants experienced significantly higher rates of necrotizing enterocolitis, seizures, oxygen dependency, and gavage feeding at discharge.

Conclusions:

  • Late preterm infants with CHDs requiring surgery are extremely vulnerable.
  • The combination of prematurity and congenital heart defects significantly increases the risk of adverse outcomes.
  • These findings underscore the need for specialized care and monitoring for this high-risk population.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...